Abstract: A crystalline form of d,l-glaucine phosphate is prepared by digesting d,l-glaucine phosphate with an alkanol. Glaucine phosphate has potent analgesic and antitussive properties, excellent flavor characteristics and stability properties and the new crystalline form has improved handling properties.
Type:
Grant
Filed:
February 2, 1981
Date of Patent:
November 9, 1982
Assignee:
The Dow Chemical Company & Merrell Dow Pharmaceuticals Incorporated
Abstract: A novel antibiotic substance and derivatives thereof, having strong antibiotic activity and .beta.-lactamase inhibiting effect and a method for producing the same by aerobic cultivation of Streptomyces A 271.
Abstract: A direct method for determination of iron in blood serum comprising reacting the blood serum with ferrozine in the presence of a reducing agent to bring iron ion into divalent form, thiosemicarbazide and hydrochloric acid at a pH between 1.7 and 2.1, without any addition of buffers and tensioactive agents and determining colorimetrically the iron content of the specimen by means of the colored complex formed between iron ion and ferrozine against a reagent blank.
Type:
Grant
Filed:
November 2, 1979
Date of Patent:
December 29, 1981
Assignee:
R.C.C. Societa' Ricerche di Chimica Clinica S.r.l.